Johns Hopkins Psychiatry Guide
Olanzapine
INDICATIONS
FDA
FDA
- Schizophrenia
- Manic or mixed episodes associated with bipolar I disorder with or without lithium or valproic acid
- Maintenance treatment of bipolar I disorder
- Bipolar I depression (olanzapine/fluoxetine)
- Treatment-resistant depression (olanzapine/fluoxetine)
- Agitation associated with schizophrenia or bipolar I mania (IM)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Management of delirium
- Nausea and vomiting
- Anorexia nervosa
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 2, 2025
Citation
Qureshi, Imran. "Olanzapine." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787519/all/Olanzapine.
Qureshi I. Olanzapine. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787519/all/Olanzapine. Accessed October 28, 2025.
Qureshi, I. (2025). Olanzapine. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787519/all/Olanzapine
Qureshi I. Olanzapine [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 28]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787519/all/Olanzapine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Olanzapine
ID - 787519
A1 - Qureshi,Imran,PharmD, BCPP
Y1 - 2025/10/02/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787519/all/Olanzapine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
